Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emergency department antiemetic trial: droperidol vs ondansetron vs placebo for nausea and vomiting
ACTRN12617000224325Phase 4Not yet recruiting
- Sponsor
- Robert Meek
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nausea ((none)) and Vomiting comparing Droperidol arm, Ondansetron arm and Placebo arm (3 arms). Primary endpoint: Proportion of participants with clinically meaningful nausea improvement. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
droperidolondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on ACTRN12617000224325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000224325.